News

Home>News

Congratulations | Successful Overseas Implantation of the Nuva® Flow Diverter in Colombia

2024-10-24
TJWY
Congratulations | Successful Overseas Implantation of the Nuva® Flow Diverter in Colombia


Recently, Beijing TJWY Technology Co., Ltd. proudly announced the successful completion of the first implantation of its self-developed Nuva® Flow Diverter in Colombia, marking the official entry of TJWY's products into the Colombian market.

 

This milestone procedure was performed by Prof. Nelson Lobelo and his outstanding neurointerventional team from SAN JOSE HEMODYNAMICS HOSPITAL.


image.png

              With Prof. Nelson Lobelo (first from the left) and his team

 

Preoperative Evaluation

 

Preoperative angiography revealed a shared trunk of bilateral anterior cerebral arteries, with a saccular aneurysm (8 mm × 6 mm) on the left anterior cerebral artery, a recurrent aneurysm (9 mm × 5 mm) on the left middle cerebral artery, and a wide-neck aneurysm (8 mm × 8 mm) on the right posterior communicating artery.

image.png

3D imaging of the left internal carotid artery


image.png

Anterior-Posterior view of the left internal carotid artery

image.png

Angiography of the right internal carotid artery


Considering the patient’s vascular condition, aneurysm size, location, and morphology, Dr. Lobelo’s team decided to first treat the distal left middle cerebral recurrent aneurysm and the left anterior cerebral saccular aneurysm, followed by treatment of the proximal right posterior communicating wide-neck aneurysm.

image.png

Post-treatment imaging of the left middle cerebral recurrent aneurysm and left anterior cerebral saccular aneurysm 

image.png

Working position angiography of the right internal carotid artery


Surgical Procedure

 

After successfully treating the left-sided aneurysms, the team proceeded to use the Nuva® Flow Diverter for the right posterior communicating artery aneurysm. The decision was made based on several advantages of the Nuva® system, including its radiopaque release-recapture segment that provides navigational guidance, full stent visibility for real-time wall apposition assessment, and the super-elastic nitinol braided structure that enhances flexibility and conformability.

 

According to the lesion measurements, the team selected the Nuva® Flow Diverter TJED-D-5.0-20 (designed for vessels approximately 4.5 mm in diameter and 28 mm in length).

image.png

Delivery of the Nuva® Flow Diverter


Using the TJWY Frepass®18Plus microcatheter, the Nuva® was smoothly delivered into the right middle cerebral artery. The microcatheter was then slowly withdrawn until the distal end of the stent opened into a “V”-shaped funnel configuration. At this point, the delivery system was slightly retracted to the intended anchoring position, and the stent was deployed using a controlled push-and-pull technique.


image.png

Immediate post-procedure angiography


Post-deployment angiography confirmed clear stent visibility, excellent wall apposition, unobstructed distal vessels and branches, and obvious contrast stagnation within the aneurysm sac—showing a distinct “crescent sign.” The delivery system was then successfully retrieved.

 

image.png

Clear visualization of the stent


Postoperative Outcome

 

Multiview angiography after the procedure showed optimal wall adherence of the Nuva® stent, with no signs of intracranial hemorrhage or ischemia. The operation concluded successfully.

 

image.png


Expert Feedback

 

Following the procedure, Prof. Nelson Lobelo highly commended the Nuva® Flow Diverter, stating:

“The Nuva® Flow Diverter features an innovative design. Compared with other flow diverters on the market, its unique radiopaque retrievable section greatly facilitates intraoperative manipulation. Once released from the microcatheter, the stent expands fully without auxiliary devices and achieves excellent wall apposition. Its superior vessel conformity and 30–35% metal surface coverage provide strong flow diversion effects, contributing to improved patient outcomes.”

 

This successful case marks an important milestone for TJWY Medical’s global presence, reinforcing the company’s commitment to delivering advanced neurovascular solutions worldwide.



Submit